Breast cancer is the most common malignancy among Western women, with up to 10% of cases attributed to genetic variants.
Novaliq’s dry eye disease therapy receives US FDA approval
Novaliq’s VEVYE (cyclosporine ophthalmic solution) 0.1% is indicated to treat the signs and symptoms of dry eye disease. Credit: megaflopp via Shutterstock.com. Biopharmaceutical company Novaliq
June 9, 2023